Jasper Therapeutics (JSPR) Assets Average (2020 - 2025)

Jasper Therapeutics' Assets Average history runs 6 years deep, the most recent figure standing at $46.6 million for Q4 2025.

• In Q4 2025, Assets Average fell 48.0% year-over-year to $46.6 million; the TTM figure through Dec 2025 stood at $46.6 million (down 48.0% YoY), while the FY2025 annual figure was $57.8 million, down 33.82% from the prior year.
• Assets Average for Q4 2025 stood at $46.6 million, down from $52.0 million in the prior quarter.
• The five-year high for Assets Average was $131.5 million in Q2 2023, with the low at $46.6 million in Q4 2025.
• The 5-year median for Assets Average is $91.6 million (2023), against an average of $87.0 million.
• The sharpest annual moves came in 2023 and 2025: Assets Average surged 91.03% in 2023, then tumbled 56.62% in 2025.
• Jasper Therapeutics' Assets Average stood at $100.4 million in 2021, then plunged by 46.5% to $53.7 million in 2022, then jumped by 91.03% to $102.6 million in 2023, then slipped by 12.66% to $89.7 million in 2024, then tumbled by 48.0% to $46.6 million in 2025.
• Business Quant data shows JSPR's Assets Average at $46.6 million in Q4 2025, $52.0 million in Q3 2025, and $52.0 million in Q2 2025.